Some have relabeled it as Pentadecapeptide Aringate or PDA (altering the acetate to an arginate) and so are prescribing it for subcutaneous administration that way, when the confusion about its standing has led to a vivid oral capsule market for BPC in what appears to generally be a grey spot https://martinqfrly.ampedpages.com/getting-my-primoteston-depot-250-mg-sydney-shogun-bpc-157-5mg-to-work-64759210